Integrated teams, data visualization, and full-service coordination between clinical, regulatory, and commercial functions can accelerate decision-making and development speed.
Ben Edwards, Chief Operating Officer at Avance Clinical, discussed common challenges in biotech, emphasizing the importance of addressing preclinical package gaps to avoid delays.
He highlighted the need for CROs with deep scientific capabilities to create a sound scientific argument for new drugs.
In the current funding climate, obtaining patient data early is crucial to inform decision-making. Edwards also noted the shift towards adaptive trial designs and the benefits of staying with the same CRO for continuity.
Effective coordination across functions requires integrated teams and data visualization.
Author's summary: Collaboration accelerates drug development.